Category: Vaccine
Lancet: Protection from previous natural infection compared with mRNA vaccination
The Lancet have published a new article comparing the protection given by a previous SARS-CoV-2 infection versus mRNA vaccination. More...
Preprint: Neutralizing antibody escape of BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
A recent preprint looks at the neutralizing antibody escape abilities for several new variants causing concern across the globe. More...
Singapore: XBB variant more prevalent in those without a previous Covid infection
Singapore’s Health Minister, Ong Ye Kung, has said that he expects the current XBB SARS-CoV-2 wave to peak in mid-November 2022. More...
USA: Florida recommends against males aged 18 to 39 receiving mRNA COVID-19 vaccines
“The State Surgeon General recommends against males aged 18 to 39 from receiving mRNA COVID-19 vaccines.” More...
WHO: 63 confirmed and probable Ebola cases, 29 deaths in Uganda
“So far, 63 confirmed and probable [Ebola] cases have been reported, including 29 deaths. More...
China: Xinjiang Covid epidemic “most difficult major public health emergency in local history”
China’s daily newspaper, the Global Times, is giving prominent coverage today to the ongoing Covid outbreak in Xinjiang, headlining it as the “most difficult major public health emergency in local history”. More...
Growth advantage for BQ.1.1 is above 100% per week
The Omicron variant BQ.1.1 appears to be in a prime position to drive the coming winter wave in Europe. More...
Preprint: Nuclear translocation of spike mRNA and protein is a novel pathogenic feature of SARS-CoV-2
A new preprint on Biorxiv looking at the nuclear translocation of S protein and mRNA in infected cells is attracting a lot of attention online today. More...
Sweden: Vaccination recommendation for children aged 12–17yrs is removed
Sweden has lifted its recommendation for vaccination of children aged from 12yrs to 17yrs. More...
UK: The Covid-19 inquiry cover-up begins
“The inquiry is becoming a farce and an exercise in cover-up.” More...